Advertisement

Annals of Hematology

, Volume 94, Issue 7, pp 1221–1223 | Cite as

Double somatic mosaic mutations in TET2 and DNMT3A—origin of peripheral T cell lymphoma in a case

  • Tran B. Nguyen
  • Mamiko Sakata-Yanagimoto
  • Rie Nakamoto-Matsubara
  • Terukazu Enami
  • Yufu Ito
  • Toshikata Kobayashi
  • Naoshi Obara
  • Yuichi Hasegawa
  • Shigeru ChibaEmail author
Letter to the Editor

Keywords

Allele Frequency Circulate Tumor Cell Normal Bone Marrow Buccal Swab NRAS Mutation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Ethical standard

Samples were obtained with written informed consent after approval by the ethics committee in the University of Tsukuba Hospital.

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

277_2015_2332_MOESM1_ESM.docx (126 kb)
ESM 1 (DOCX 125 kb)

References

  1. 1.
    Sakata-Yanagimoto M, Enami T, Yoshida K, Shiraishi Y, Ishii R, Miyake Y, Muto H, Tsuyama N, Sato-Otsubo A, Okuno Y, Sakata S, Kamada Y, Nakamoto-Matsubara R, Tran NB, Izutsu K, Sato Y, Ohta Y, Furuta J, Shimizu S, Komeno T, Sato Y, Ito T, Noguchi M, Noguchi E, Sanada M, Chiba K, Tanaka H, Suzukawa K, Nanmoku T, Hasegawa Y, Nureki O, Miyano S, Nakamura N, Takeuchi K, Ogawa S, Chiba S (2014) Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat Genet 46(2):171–175. doi: 10.1038/ng.2872 CrossRefPubMedGoogle Scholar
  2. 2.
    Palomero T, Couronne L, Khiabanian H, Kim MY, Ambesi-Impiombato A, Perez-Garcia A, Carpenter Z, Abate F, Allegretta M, Haydu JE, Jiang X, Lossos IS, Nicolas C, Balbin M, Bastard C, Bhagat G, Piris MA, Campo E (2014) Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral. T Cell Lymphom 46(2):166–170. doi: 10.1038/ng.2873 Google Scholar
  3. 3.
    Lin TL, Nagata Y, Kao HW, Sanada M, Okuno Y, Huang CF, Liang DC, Kuo MC, Lai CL, Lee EH, Shih YS, Tanaka H, Shiraishi Y, Chiba K, Lin TH, Wu JH, Miyano S, Ogawa S, Shih LY (2014) Clonal leukemic evolution in myelodysplastic syndromes with TET2 and IDH1/2 mutations. Haematologica 99(1):28–36. doi: 10.3324/haematol.2013.091249 CrossRefPubMedCentralPubMedGoogle Scholar
  4. 4.
    Aslanyan MG, Kroeze LI, Langemeijer SM, Koorenhof-Scheele TN, Massop M, van Hoogen P, Stevens-Linders E, van de Locht LT, Tonnissen E, van der Heijden A, da Silva-Coelho P, Cilloni D, Saglio G, Marie JP, Tang R, Labar B, Amadori S, Muus P, Willemze R, Marijt EW, de Witte T, van der Reijden BA, Suciu S, Jansen JH (2014) Clinical and biological impact of TET2 mutations and expression in younger adult AML patients treated within the EORTC/GIMEMA AML-12 clinical trial. Ann Hematol 93(8):1401–1412. doi: 10.1007/s00277-014-2055-7 PubMedGoogle Scholar
  5. 5.
    Couronne L, Bastard C, Bernard OA (2012) TET2 and DNMT3A mutations in human T-cell lymphoma. N Engl J Med 366(1):95–96. doi: 10.1056/NEJMc1111708 CrossRefPubMedGoogle Scholar
  6. 6.
    Youssoufian H, Pyeritz RE (2002) Mechanisms and consequences of somatic mosaicism in humans. Nat Rev Genet 3(10):748–758. doi: 10.1038/nrg906 CrossRefPubMedGoogle Scholar
  7. 7.
    Foulkes WD, Real FX (2013) Many mosaic mutations. Curr Oncol (Toronto, Ont) 20(2):85–87. doi: 10.3747/co.20.1449 Google Scholar
  8. 8.
    Frank SA (2014) Somatic mosaicism and disease. Curr Biol CB 24(12):R577–R581. doi: 10.1016/j.cub.2014.05.021 CrossRefGoogle Scholar
  9. 9.
    Doisaki S, Muramatsu H, Shimada A, Takahashi Y, Mori-Ezaki M, Sato M, Kawaguchi H, Kinoshita A, Sotomatsu M, Hayashi Y, Furukawa-Hibi Y, Yamada K, Hoshino H, Kiyoi H, Yoshida N, Sakaguchi H, Narita A, Wang X, Ismael O, Xu Y, Nishio N, Tanaka M, Hama A, Koike K, Kojima S (2012) Somatic mosaicism for oncogenic NRAS mutations in juvenile myelomonocytic leukemia. Blood 120(7):1485–1488. doi: 10.1182/blood-2012-02-406090 CrossRefPubMedGoogle Scholar
  10. 10.
    Ismael O, Shimada A, Hama A, Elshazley M, Muramatsu H, Goto A, Sakaguchi H, Tanaka M, Takahashi Y, Yinyan X, Fukuda M, Miyajima Y, Yamashita Y, Horibe K, Hanada R, Ito M, Kojima S (2012) De novo childhood myelodysplastic/myeloproliferative disease with unique molecular characteristics. Br J Haematol 158(1):129–137. doi: 10.1111/j.1365-2141.2012.09140.x CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Tran B. Nguyen
    • 1
  • Mamiko Sakata-Yanagimoto
    • 1
    • 2
    • 3
  • Rie Nakamoto-Matsubara
    • 1
  • Terukazu Enami
    • 3
  • Yufu Ito
    • 3
  • Toshikata Kobayashi
    • 3
  • Naoshi Obara
    • 1
    • 2
    • 3
  • Yuichi Hasegawa
    • 1
    • 2
    • 3
  • Shigeru Chiba
    • 1
    • 2
    • 3
    • 4
    Email author
  1. 1.Department of Hematology, Comprehensive Human SciencesUniversity of TsukubaTsukubaJapan
  2. 2.Department of Hematology, Faculty of MedicineUniversity of TsukubaTsukubaJapan
  3. 3.Department of HematologyUniversity of Tsukuba HospitalTsukubaJapan
  4. 4.Life Science center, Tsukuba Advanced Research AllianceUniversity of TsukubaTsukubaJapan

Personalised recommendations